Welcome to Medications.com

CORRECTION Bayer lowers drug unit's margin target after Yasmin ... - Forbes

The ruling, which declared Bayer's patent on Yasmin invalid, extends a series of setbacks in Bayer's pharmaceuticals business. Earlier this year, its cancer ...

http://www.forbes.com/markets/fee... | Posted: Tue Mar 04 04:34:03 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea